Ontology highlight
ABSTRACT: Objectives
Patients with systemic lupus erythematosus (SLE) often display modest elevations of C-reactive protein (CRP) despite raised disease activity and increased interleukin (IL-) 6. We asked to what extent IL-6 levels, the CRP polymorphism rs1205, and the type I interferon (IFN) gene signature affects the basal CRP levels in patients with SLE during a quiescent phase of the disease.Methods
CRP and IL-6 were analyzed in plasma from 57 patients meeting established classification criteria for SLE. The CRP polymorphism rs1205 was assessed and gene expression analyzed including four type I IFN-regulated genes (IGS).Results
CRP was increased in patients with detectable IL-6 levels (p=0.001) and decreased among IGS-positive subjects (p=0.033). A multiple linear regression model revealed IL-6 to have a positive association with CRP levels, whereas both IGS-positivity and CRP genotype (rs1205) AA/GA were negatively associated with CRP-levels.Conclusion
Our data offer an explanation to the modest CRP levels seen in viral infections and IFN-? driven autoimmunity and corroborate prior observations showing an IFN-? dependent downregulation of CRP. The latter observation, together with the fact that the CRP-lowering polymorphism rs1205 is overrepresented in human SLE, could explain low basal CRP and inadequate CRP-responses among patients with active SLE.
SUBMITTER: Enocsson H
PROVIDER: S-EPMC7876312 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
Enocsson Helena H Gullstrand Birgitta B Eloranta Maija-Leena ML Wetterö Jonas J Leonard Dag D Rönnblom Lars L Bengtsson Anders A AA Sjöwall Christopher C
Frontiers in immunology 20210128
<h4>Objectives</h4>Patients with systemic lupus erythematosus (SLE) often display modest elevations of C-reactive protein (CRP) despite raised disease activity and increased interleukin (IL-) 6. We asked to what extent IL-6 levels, the CRP polymorphism rs1205, and the type I interferon (IFN) gene signature affects the basal CRP levels in patients with SLE during a quiescent phase of the disease.<h4>Methods</h4>CRP and IL-6 were analyzed in plasma from 57 patients meeting established classificati ...[more]